Barclays’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$411K Sell
15,198
-60,161
-80% -$2.02M ﹤0.01% 3297
2025
Q4
$3.23M Buy
75,359
+24,294
+48% +$916K ﹤0.01% 2578
2025
Q3
$1.45M Sell
51,065
-8,741
-15% -$261K ﹤0.01% 3126
2025
Q2
$1.12M Buy
59,806
+30,595
+105% +$580K ﹤0.01% 3268
2025
Q1
$526K Sell
29,211
-2,125
-7% -$43.1K ﹤0.01% 3506
2024
Q4
$527K Buy
31,336
+3,991
+15% +$76.5K ﹤0.01% 3790
2024
Q3
$442K Buy
27,345
+16,772
+159% +$197K ﹤0.01% 3857
2024
Q2
$86.9K Sell
10,573
-4,484
-30% -$46.9K ﹤0.01% 3973
2024
Q1
$223K Sell
15,057
-9,593
-39% -$129K ﹤0.01% 4064
2023
Q4
$357K Buy
24,650
+20,485
+492% +$209K ﹤0.01% 4094
2023
Q3
$45K Sell
4,165
-385
-8% -$4.63K ﹤0.01% 3916
2023
Q2
$58.7K Sell
4,550
-5,321
-54% -$71.9K ﹤0.01% 3768
2023
Q1
$130K Buy
9,871
+5,237
+113% +$83.2K ﹤0.01% 4039
2022
Q4
$69.5K Buy
4,634
+3,902
+533% +$35.8K ﹤0.01% 4421
2022
Q3
$9K Sell
732
-134
-15% -$1.81K ﹤0.01% 4363
2022
Q2
$10K Sell
866
-3,987
-82% -$80.1K ﹤0.01% 4631
2022
Q1
$145K Sell
4,853
-15,886
-77% -$430K ﹤0.01% 3607
2021
Q4
$550K Sell
20,739
-14,985
-42% -$452K ﹤0.01% 3162
2021
Q3
$1.3M Buy
35,724
+12,079
+51% +$475K ﹤0.01% 2624
2021
Q2
$1.03M Sell
23,645
-18,747
-44% -$708K ﹤0.01% 2643
2021
Q1
$1.45M Buy
42,392
+27,003
+175% +$1.07M ﹤0.01% 2534
2020
Q4
$538K Sell
15,389
-3,041
-17% -$88K ﹤0.01% 3191
2020
Q3
$441K Sell
18,430
-6,466
-26% -$159K ﹤0.01% 3323
2020
Q2
$456K Buy
24,896
+4,050
+19% +$72.9K ﹤0.01% 3407
2020
Q1
$325K Sell
20,846
-3,725
-15% -$79.3K ﹤0.01% 3930
2019
Q4
$526K Buy
24,571
+3,621
+17% +$74.6K ﹤0.01% 4257
2019
Q3
$392K Buy
20,950
+4,038
+24% +$83.4K ﹤0.01% 4439
2019
Q2
$442K Buy
16,912
+6,101
+56% +$138K ﹤0.01% 4425
2019
Q1
$278K Buy
10,811
+801
+8% +$18.3K ﹤0.01% 4578
2018
Q4
$230K Sell
10,010
-16,946
-63% -$478K ﹤0.01% 4480
2018
Q3
$866K Sell
26,956
-31,555
-54% -$947K ﹤0.01% 3769
2018
Q2
$1.66M Sell
58,511
-34,156
-37% -$1.22M ﹤0.01% 2747
2018
Q1
$3.28M Buy
92,667
+50,068
+118% +$2M ﹤0.01% 1978
2017
Q4
$1.65M Buy
42,599
+25,769
+153% +$981K ﹤0.01% 2617
2017
Q3
$427K Buy
16,830
+513
+3% +$12.5K ﹤0.01% 3774
2017
Q2
$446K Buy
16,317
+13,113
+409% +$359K ﹤0.01% 3639
2017
Q1
$106K Sell
3,204
-1,227
-28% -$31.3K ﹤0.01% 4834
2016
Q4
$105K Buy
4,431
+664
+18% +$19K ﹤0.01% 4708
2016
Q3
$137K Sell
3,767
-4,218
-53% -$121K ﹤0.01% 4275
2016
Q2
$178K Buy
7,985
+3,268
+69% +$81.3K ﹤0.01% 4003
2016
Q1
$94K Buy
4,717
+4,524
+2,344% +$112K ﹤0.01% 4395
2015
Q4
$6K Buy
193
+69
+56% +$2.09K ﹤0.01% 5531
2015
Q3
$2K Sell
124
-1,834
-94% -$54.7K ﹤0.01% 6362
2015
Q2
$58K Buy
1,958
+977
+100% +$37.3K ﹤0.01% 5053
2015
Q1
$29K Sell
981
-1,045
-52% -$28.7K ﹤0.01% 5632
2014
Q4
$40K Sell
2,026
-2,777
-58% -$56.2K ﹤0.01% 5883
2014
Q3
$48K Buy
4,803
+1,749
+57% +$49.4K ﹤0.01% 5915
2014
Q2
$90K Sell
3,054
-2,180
-42% -$74.1K ﹤0.01% 5498
2014
Q1
$156K Buy
5,234
+1,960
+60% +$69.9K ﹤0.01% 5036
2013
Q4
$64K Buy
3,274
+148
+5% +$4.34K ﹤0.01% 6006
2013
Q3
$94K Sell
3,126
-1,012
-24% -$36.9K ﹤0.01% 5659
2013
Q2
$139K Buy
+4,138
New +$187K ﹤0.01% 5522

Other funds holding RIGL